Mr Price Group Ltd (MRP)
Johannesburg Stock Exchange · South Africa · prices in ZAC · close of 27 Oct 2026
Key indicators
| Last close | ZAC 17,220.00 |
|---|---|
| 52-week range | 14,628.00 – 22,303.00 |
| Return, 1 month / 3 months | +5.7% / +4.1% |
| Return, 1 year / 3 years | −16.1% / +51.0% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 34.7% |
| Worst drawdown (1 year) | -31.7% |
| Average daily value traded | 12,341.22M ZAC |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mr Price Group is a South African retailer that sells clothing, footwear, accessories and homeware at value prices. Its store chains serve everyday shoppers, offering fashion for men, women and children alongside bedding, towels and household goods. The company is based in Durban and runs its shops mainly in South Africa, with some presence in other African markets, and it also sells through its own online channels.
On this site Mr Price Group Ltd appears as a stock on the Johannesburg Stock Exchange (South Africa), code MRP, with prices in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mr Price Group Ltd (MRP) trades on the Johannesburg Stock Exchange in South Africa. It last closed at ZAC 17,220.00 on 27 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 87 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.1% and over the last three months it rose 4.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.4% | ||
| From 52-week high | -21.7% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.1% | ||
| 6-month return | 12.7% | ||
| 12-month return, skipping the last month | -20.6% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.7% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 12,341.22M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | 74 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | +5.7% |
| 3 months | +4.1% |
| 6 months | +12.7% |
| 1 year | −16.1% |
| 3 years | +51.0% |
| 5 years | +6.4% |
Signals
| 50-day / 200-day average | 16,527.46 / 16,331.18 |
|---|---|
| Golden / death cross (60 days) | Golden, 53 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 459.14 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jul 2026 | ZAC 592.8000 |
| 10 Dec 2025 | ZAC 323.2000 |
| 2 Jul 2025 | ZAC 593.5000 |
| 11 Dec 2024 | ZAC 303.6000 |
| 3 Jul 2024 | ZAC 526.8000 |
| 12 Dec 2023 | ZAC 283.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.